IRC
GOSS icon

Investors Research Corp’s Gossamer Bio GOSS Stock Holding History

Investors Research Corp’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-69
Closed -$1K – 1145
2022
Q3 		$1K Hold
69
– – ﹤0.01% 1030
2022
Q2 		$1K Hold
69
– – ﹤0.01% 1026
2022
Q1 		$1K Hold
69
– – ﹤0.01% 971
2021
Q4 		$1K Hold
69
– – ﹤0.01% 936
2021
Q3 		$1K Hold
69
– – ﹤0.01% 951
2021
Q2 		$1K Hold
69
– – ﹤0.01% 936
2021
Q1 		$1K Hold
69
– – ﹤0.01% 930
2020
Q4 		$1K Hold
69
– – ﹤0.01% 1029
2020
Q3 		$1K Buy
+69
New +$915 ﹤0.01% 1041

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Investors Research Corp's GOSS Position: Q4 2022 in Review

Investors Research Corp sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 69 shares — an estimated $1K sold.

Investors Research Corp first reported a position in GOSS in Q3 2020 and held it in 9 quarters. The position peaked at $1K in Q3 2022. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Investors Research Corp reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Investors Research Corp sold 69 Gossamer Bio shares in Q4 2022, an estimated $1K.
  • Investors Research Corp first reported a position in Gossamer Bio in Q3 2020 and held it in 9 quarters.
  • Investors Research Corp's Gossamer Bio position peaked at $1K in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Investors Research Corp's 13F filing for Q4 2022, filed 6 Feb 2023.